Stock comparison
DEXCOM INC is 9.7x more valuable than Pulse Biosciences, Inc. by market capitalization ($32.62 B vs $3.38 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
DXCM is larger
DEXCOM INC is 9.7x more valuable than Pulse Biosciences, Inc. by market capitalization ($32.62 B vs $3.38 B).
Market value leader
DXCM
DEXCOM INC is 9.7x more valuable than Pulse Biosciences, Inc. by market capitalization ($32.62 B vs $3.38 B).
Revenue leader
DXCM
PLSE: $350.00K vs DXCM: $4.66B.
Profit leader
DXCM
PLSE: -$72.78M vs DXCM: $836.30M.
Margin leader
DXCM
PLSE: -20794.6% vs DXCM: 17.9% net margin.
| Metric | PLSE | DXCM |
|---|---|---|
| Market cap | $3.38 B | $32.62 B |
| US-listed rank | #1735 | #444 |
| Revenue (latest FY) | $350.00K | $4.66B |
| Net income (latest FY) | -$72.78M | $836.30M |
| Net margin | -20794.6% | 17.9% |
| P/E (trailing FY) | - | 39.0x |
| SEC filings | 616 | 2,566 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
DEXCOM INC is 9.7x more valuable than Pulse Biosciences, Inc. by market capitalization ($32.62 B vs $3.38 B).
In their latest fiscal years, Pulse Biosciences, Inc. reported $350.00K in revenue while DEXCOM INC reported $4.66B.
Full pages: Pulse Biosciences, Inc. and DEXCOM INC, or browse the full rankings.